Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$68.86 - $83.34 $1.49 Million - $1.81 Million
-21,700 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$96.85 - $148.25 $920,075 - $1.41 Million
9,500 Added 77.87%
21,700 $2.15 Million
Q3 2020

Nov 16, 2020

BUY
$122.47 - $213.56 $318,422 - $555,256
2,600 Added 27.08%
12,200 $1.73 Million
Q2 2020

Aug 14, 2020

SELL
$185.52 - $231.25 $614,813 - $766,362
-3,314 Reduced 25.66%
9,600 $1.89 Million
Q4 2019

Feb 14, 2020

SELL
$146.12 - $215.82 $43,836 - $64,746
-300 Reduced 2.27%
12,914 $2.67 Million
Q2 2019

Aug 14, 2019

BUY
$111.45 - $128.93 $378,930 - $438,362
3,400 Added 34.64%
13,214 $1.7 Million
Q1 2019

May 15, 2019

BUY
$89.61 - $117.78 $879,432 - $1.16 Million
9,814 New
9,814 $1.16 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.76B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Susquehanna International Securities, Ltd. Portfolio

Follow Susquehanna International Securities, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.